TD Capital Management’s TRACON Pharmaceuticals, Inc. Common Stock TCON Stock Holding History

TD Capital Management’s Portfolio TCON Stock Details TCON Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q3	–	Sell	-1	Closed	-$2K	–	163
2015 Q2	$2K	Buy	+1	New	+$2.35K	﹤0.01%	143

Other funds holding TCON

NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

Visium Asset Management New York $1.43B AUM 3.58% 1-Year Est. Return

Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return

QVT Financial New York $1.37B AUM 148.1% 1-Year Est. Return

Wall Street Associates Lajolla, California $151M AUM 30.3% 1-Year Est. Return

J. Goldman & Co New York $3.44B AUM 33.8% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Candriam SCA Strassen, Luxembourg, Luxembourg $19.3B AUM 39.18% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

TD Capital Management's TCON Position: Q3 2015 in Review

TD Capital Management sold out of TRACON Pharmaceuticals, Inc. Common Stock (TCON) in Q3 2015, closing a stake of 1 share — an estimated $2K sold.

TD Capital Management first reported a position in TCON in Q2 2015 and held it in 1 quarter. The position peaked at $2K in Q2 2015. 27 funds tracked by Wall St. Rank hold TCON as of Q3 2015.

TD Capital Management reported no remaining TRACON Pharmaceuticals, Inc. Common Stock position as of Q3 2015 after selling out during the quarter.
TD Capital Management sold 1 TRACON Pharmaceuticals, Inc. Common Stock share in Q3 2015, an estimated $2K.
TD Capital Management first reported a position in TRACON Pharmaceuticals, Inc. Common Stock in Q2 2015 and held it in 1 quarter.
TD Capital Management's TRACON Pharmaceuticals, Inc. Common Stock position peaked at $2K in Q2 2015.
27 funds tracked by Wall St. Rank held TRACON Pharmaceuticals, Inc. Common Stock as of Q3 2015.

Based on TD Capital Management's 13F filing for Q3 2015, filed 5 Nov 2015.